We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $69.2B
1-Year Est. Return 41.24%
This Fund
S&P 500
This Quarter Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
Cap. Flow
-$7.07B
Cap. Flow %
-10.23%
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Miscellaneous 27.25%
3 Industrials 6.93%
4 Consumer Staples 6.67%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNST icon
1851
The Honest Company
HNST
$638M
$46.1K ﹤0.01%
12,593
-1,136
-8% -$3.83K
CLNE icon
1852
Clean Energy Fuels
CLNE
$364M
$44.1K ﹤0.01%
21,519
-3,685
-15% -$7.83K
LPRO
1853
DELISTED
Open Lending Corp
LPRO
$42.6K ﹤0.01%
13,684
-978
-7% -$2K
BMBL icon
1854
Bumble
BMBL
$383M
$42.5K ﹤0.01%
13,271
+2,845
+27% +$9.73K
HTZ icon
1855
Hertz
HTZ
$820M
$41.5K ﹤0.01%
18,314
-343
-2% -$1.87K
BLND icon
1856
Blend Labs
BLND
$364M
$41.3K ﹤0.01%
24,127
-4,480
-16% -$7.15K
BGS icon
1857
B&G Foods
BGS
$267M
$41K ﹤0.01%
10,304
-1,006
-9% -$4.67K
WTI icon
1858
W&T Offshore
WTI
$577M
$40.4K ﹤0.01%
12,823
-1,569
-11% -$5.82K
PALI icon
1859
Palisade Bio
PALI
$364M
$40.4K ﹤0.01%
+19,325
New +$38K
VSTM icon
1860
Verastem
VSTM
$743M
$39.9K ﹤0.01%
+10,457
New +$50.6K
ELDN icon
1861
Eledon Pharmaceuticals
ELDN
$245M
$39.7K ﹤0.01%
10,086
-746
-7% -$2.71K
IPSC icon
1862
Century Therapeutics
IPSC
$382M
$39.5K ﹤0.01%
+16,137
New +$36.9K
AVXL icon
1863
Anavex Life Sciences
AVXL
$265M
$39.1K ﹤0.01%
15,109
-1,720
-10% -$5.09K
OLPX
1864
DELISTED
Olaplex Holdings
OLPX
$38.6K ﹤0.01%
18,853
-1,514
-7% -$3.09K
AKBA icon
1865
Akebia Therapeutics
AKBA
$270M
$38.6K ﹤0.01%
33,836
-2,868
-8% -$3.41K
ALVO icon
1866
Alvotech
ALVO
$1.9B
$37.8K ﹤0.01%
10,233
-4,543
-31% -$16.2K
CMPX icon
1867
Compass Therapeutics
CMPX
$429M
$37.6K ﹤0.01%
17,167
-1,536
-8% -$4.54K
NABL icon
1868
N-able
NABL
$767M
$37.6K ﹤0.01%
10,232
-871
-8% -$3.62K
DNUT icon
1869
Krispy Kreme
DNUT
$586M
$37.2K ﹤0.01%
10,534
-650
-6% -$2.32K
REAX icon
1870
Real REMAX Group Inc. Common Stock
REAX
$407M
$37.2K ﹤0.01%
2,043
-6
-0.3% -$122
LRMR icon
1871
Larimar Therapeutics
LRMR
$398M
$37K ﹤0.01%
12,125
+425
+4% +$1.69K
SPCE icon
1872
Virgin Galactic
SPCE
$461M
$36.6K ﹤0.01%
+12,650
New +$41.3K
VGZ icon
1873
Vista Gold
VGZ
$327M
$36.1K ﹤0.01%
+18,925
New +$41.3K
EVGO icon
1874
EVgo
EVGO
$214M
$34.1K ﹤0.01%
17,873
-942
-5% -$1.9K
EU
1875
enCore Energy
EU
$241M
$33.4K ﹤0.01%
25,531
-1,166
-4% -$1.96K

Similar funds

ProShare Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.

  • ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
  • ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
  • ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
  • ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
  • ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
  • ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
  • ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.